171 related articles for article (PubMed ID: 37787838)
41. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
[TBL] [Abstract][Full Text] [Related]
42. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
43. The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification.
Cui T; Wang J; Wang Z
Front Immunol; 2022; 13():876415. PubMed ID: 35860246
[TBL] [Abstract][Full Text] [Related]
44. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
[TBL] [Abstract][Full Text] [Related]
45. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
[TBL] [Abstract][Full Text] [Related]
46. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
[TBL] [Abstract][Full Text] [Related]
47. Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe Infection.
Liang J; Xu X; Chen Z; Yu J; Tang Y
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e360-e362. PubMed ID: 38691058
[TBL] [Abstract][Full Text] [Related]
48. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
49. [Expression Profile and Clinical Significance of Cytokines and Chemokines in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis].
Gao Y; Zheng Y; Zhang WH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):268-273. PubMed ID: 36765510
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic stem cell transplantation complicated with EBV associated hemophagocytic lymphohistiocytosis in a patient with DOCK2 deficiency.
Aytekin ES; Çağdaş D; Tan Ç; Çavdarlı B; Bilgiç I; Tezcan İ
Turk J Pediatr; 2021; 63(6):1072-1077. PubMed ID: 35023658
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
52. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
Liu JH; Liu W; Li YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
[TBL] [Abstract][Full Text] [Related]
53. A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis.
Kao RL; Jacobsen AA; Billington CJ; Yohe SL; Beckman AK; Vercellotti GM; Pearson DR
Blood Cells Mol Dis; 2022 Mar; 93():102636. PubMed ID: 34864445
[TBL] [Abstract][Full Text] [Related]
54. Virus-triggered secondary hemophagocytic lymphohistiocytosis.
Imashuku S; Morimoto A; Ishii E
Acta Paediatr; 2021 Oct; 110(10):2729-2736. PubMed ID: 34096649
[TBL] [Abstract][Full Text] [Related]
55. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
56. Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.
Huang Z; Xie J
Medicine (Baltimore); 2021 Mar; 100(11):e25188. PubMed ID: 33726009
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
Front Immunol; 2022; 13():882589. PubMed ID: 35479073
[TBL] [Abstract][Full Text] [Related]
58. Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
Weber T; Wickenhauser C; Monecke A; Gläser C; Stadler M; Desole M; Ligeti K; Behrmann C; Müller-Tidow C; Müller LP
Transpl Infect Dis; 2014 Dec; 16(6):988-92. PubMed ID: 25179757
[TBL] [Abstract][Full Text] [Related]
59. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
[TBL] [Abstract][Full Text] [Related]
60. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
Balamuth NJ; Nichols KE; Paessler M; Teachey DT
J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
